The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Erichev V.P.

Krasnov Research Institute of Eye Diseases

Zinina V.S.

Krasnov Research Institute of Eye Diseases

Safonova D.M.

Krasnov Research Institute of Eye Diseases

Minoxidil-induced ophthalmic hypertension (case report)

Authors:

Erichev V.P., Zinina V.S., Safonova D.M.

More about the authors

Journal: Russian Annals of Ophthalmology. 2024;140(2‑2): 90‑93

Read: 4986 times


To cite this article:

Erichev VP, Zinina VS, Safonova DM. Minoxidil-induced ophthalmic hypertension (case report). Russian Annals of Ophthalmology. 2024;140(2‑2):90‑93. (In Russ.)
https://doi.org/10.17116/oftalma202414002290

Recommended articles:
Long-term outcomes of phakic intraocular lens implantation in high myopia. Russian Annals of Ophthalmology. 2025;(1):28-31
Modern devi­ces for microinvasive glaucoma surgery. Russian Annals of Ophthalmology. 2025;(5):101-108
Comparative evaluation of tono­metry methods in kera­toconus. Russian Annals of Ophthalmology. 2025;(6):7-13

References:

  1. Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777-2786. https://doi.org/10.2147/DDDT.S214907
  2. Stoehr JR, Choi JN, Colavincenzo M, Vanderweil S. Off-Label Use of Topical Minoxidil in Alopecia: A Review. Am J Clin Dermatol. 2019;20(2):237-250.  https://doi.org/10.1007/s40257-018-0409-y
  3. Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746.  https://doi.org/10.1016/j.jaad.2020.06.1009
  4. Friedman ES, Friedman PM, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol. 2002;46(2):309-312.  https://doi.org/10.1067/mjd.2002.119104.5
  5. Le A, Mukesh BN, McCarty CA, Taylor HR. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Opthalm Visual Sci. 2003;44(9):3783-3789. https://doi.org/10.1167/iovs.03-0077
  6. Czudowska MA, Ramdas WD, Wolfs RC, Hofman A, De Jong PT, Vingerling JR, Jansonius NM. Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study. Ophthalmology. 2010;117(9):1705-1712. https://doi.org/10.1016/j.ophtha.2010.01.034
  7. Kang HG, Kim JW. Effect of Minoxidil on Trabecular Outflow via the Paracellular Pathway. Korean J Ophthalmol. 2020;34(2):97-105.  https://doi.org/10.3341/kjo.2019.0124
  8. Gombos GM. Bilateral optic neuritis following minoxidil administration. Ann Ophthalmol. 1983;15(3):259-261. 
  9. Aktas H, Alan S, Turkoglu EB, Sevik O. Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy? J Clin Diagn Res. 2016; 10(8):WD01-02.  https://doi.org/10.7860/JCDR/2016/19679.8250
  10. Venkatesh R, Pereira A, Reddy NG, Yadav NK. Retinal artery occlusion as a probable idiosyncratic reaction to topical minoxidil: a case report. J Med Case Rep. 2021;15(1):493.  https://doi.org/10.1186/s13256-021-03114-8
  11. Venkatesh R, Pereira A, Jain K, Yadav NK. Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone — a case report. BMC Ophthalmol. 2020;20(1):219.  https://doi.org/10.1186/s12886-020-01499-6
  12. Scarinci F, Mezzana P, Pasquini P, Colletti M, Cacciamani A. Central chorioretinopathy associated with topical use of minoxidil 2% for treatment of baldness. Cutan Ocul Toxicol. 2012;31(2):157-159.  https://doi.org/10.3109/15569527.2011.613427
  13. Guillon-Rolf R, Boutboul S, Borderie V. [Central serous chorioretinopathy associated with minoxidil 2]. J Fr Ophtalmol. 2020;43(10):e369-e370. https://doi.org/10.1016/j.jfo.2020.03.007
  14. Goins KM, Karp KO, Gabrielian K. Minoxidil-induced alteration of corneal topography after radial keratotomy. J Cataract Refract Surg. 1998;24(5): 612-618.  https://doi.org/10.1016/s0886-3350(98)80255-1
  15. Ishida I, Saika S, Ohnishi Y. Effect of minoxidil on rabbit lens epithelial cell behavior in vitro and in situ. Graefes Arch Clin Exp Ophthalmol. 2001;239(10): 770-777.  https://doi.org/10.1007/s004170100336
  16. Handa JT, Murad S, Jaffe GJ. Inhibition of cultured human RPE cell proliferation and lysyl hydroxylase activity by hydroxy derivatives of minoxidil. Invest Ophthalmol Vis Sci. 1994; 35(2):463-469. 
  17. Sharir M. Topical minoxidil for glaucoma filtration surgery in the rabbit. Exp Eye Res. 1994;59(6):707-714.  https://doi.org/10.1006/exer.1994.1156
  18. Nathanson JA. Nitrovasodilators as a new class of ocular hypotensive agents. J Pharmacol Exp Ther. 1992;260(3):956-965. 
  19. Kang HG, Kim JW. Effect of Minoxidil on Trabecular Outflow via the Paracellular Pathway. Korean J Ophthalmol. 2020;34(2):97-105.  https://doi.org/10.3341/kjo.2019.0124

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.